Elysium Company

Breakthroughs in aging research are no longer a myth of science fiction but scientific fact. Elysium makes first-of-their-kind health products and technologies backed by partnerships with institutions at the forefront of aging research.


Connections from

Last Funding Type: Series C
Technology: Clinical Data Management Platforms
Founded Date: 2014-01-01
Industry: Digital Biomarkers
Funding Status: Late Stage Venture
Headquarters: New York, New York, United States
Number Of Exists: 11-50
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-21
Total Funding: 71209000
Investors Number: 16